Caris Life Sciences (CAI) Non-Current Assets (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Non-Current Assets of $148.2 million for Q1 2026, up 15.91% quarter-over-quarter from $127.9 million in Q4 2025.
Caris Life Sciences (CAI) Non-Current Assets (2024 - 2026) Analysis & Trends
Caris Life Sciences' Non-Current Assets history runs 3 years deep, the most recent figure standing at $148.2 million for Q1 2026.
- In Q1 2026, Non-Current Assets changed N/A year-over-year to $148.2 million; the TTM figure through Mar 2026 stood at $528.1 million (changed N/A YoY), while the FY2025 annual figure was $127.9 million, changed 0.11% from the prior year.
- Non-Current Assets for Q1 2026 stood at $148.2 million, up from $127.9 million in the prior quarter.
- The five-year high for Non-Current Assets was $148.2 million in Q1 2026, with the low at $121.7 million in Q2 2025.
- The 3-year median for Non-Current Assets is $128.0 million (2024), against an average of $131.2 million.
- Peak annual rise in Non-Current Assets reached 0.11% in 2025, while the deepest fall reached 0.11% in 2025.
- Caris Life Sciences' Non-Current Assets stood at $128.0 million in 2024, then fell by 0.11% to $127.9 million in 2025, then climbed by 15.91% to $148.2 million in 2026.
- Business Quant data shows CAI's Non-Current Assets at $148.2 million in Q1 2026, $127.9 million in Q4 2025, and $130.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 171.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171.79 Mn |
| Mar 31, 2026 | 148.21 Mn |
| Dec 31, 2025 | 127.86 Mn |
| Sep 30, 2025 | 130.33 Mn |
| Jun 30, 2025 | 121.74 Mn |
| Dec 31, 2024 | 128.01 Mn |